RXRX
#2073
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.4 4 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.43%
Variación mensual
+13.53%
Variación en los últimos 6 meses
-1.15%
Cambio anual
-29.07%
Cierres anteriores
3.4 9
Open
3.4 4
Mínimo
3.4 4
Máximo
3.4 4
Volumen
135
Financials
- Market Capitalization 1.84 B
- Employee 600
- Founded 2013
- CEO Najat Khan
- Website www.recursion.com
- Headquarter Delaware, United States
- FIGI BBG00PQ4XJ45
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.84
Relación precio/flujo de caja
24.5
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2055 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.75 USD | -1.00% | +0.14% | +10.00% | +9.77% | 1.89 B USD | ||
| 2056 |  SEPN Septerna, Inc. - Common Stock | 40.47 USD | +0.55% | -2.34% | +19.13% | +83.87% | 1.89 B USD | ||
| 2075 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 13.11 USD | -0.61% | +3.64% | +21.73% | -4.45% | 1.84 B USD | ||
| 2079 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 123.93 USD | -1.12% | +23.00% | +55.05% | +53.80% | 1.82 B USD |